SUMMARY Trace elements were estimated in the spinal cord, liver and bone of five patients dying of motor neuron disease and five control subjects dying of non-neurological disease. The content of selenium in cord and liver and the cord manganese level were significantly increased in the motor neuron disease patients. These findings are discussed in terms of the possible aetiology of motor neuron disease.
mercury910 toxicity, such patients improve either with chelation therapy or removal from the contaminated environment. Patients with motor neuron disease do not and the significance of reports of increased lead levels in the spinal cord of patients dying of motor neuron disease1112 is uncertain. It seems likely that these represent a secondary rather than a primary effect.12 13 The possibility remains that motor neuron disease arises as a result of a metabolic disturbance of motor neurons. The RNA content of motor neurons has been reported to be reduced14-16 and it has recently been suggested that these observations might reflect defective enzymatic DNA repair mechanisms.'7 While this is an attractive hypothesis there is no direct supporting evidence. Trace elements are of crucial importance in metabolism, particularly in respect of enzyme function. We have previously found the CSF cobalt level to be reduced in motor neuron disease patients as compared with a control group free of neurological disease.'8 Acknowledging that CSF levels might not reflect tissue concentrations we estimated the content of a range of trace elements in spinal cord, liver and bone of patients dying of motor neuron disease compared with a control group dying of non-neurological disease.
Methods
Subjects and sample preparation Specimens of spinal cord, liver and bone were obtained post mortem from five patients who had died of motor neuron disease and five control subjects who had died of nonneurological disease. The diagnoses of the control population are given in table 1, and the clinical features of the motor neuron disease patients in table 2. The diagnosis of motor neuron disease was established in each case only after full in-patient investigation including appropriate blood tests and radiological studies, CSF examination and electrophysiological studies.
Segments of spinal cord measuring approximately 1 cm were taken at three levels, viz cervical, mid-thoracic and lumbar enlargement. The specimen of bone was a thoracic spinous process obtained during the removal of the cord. The liver specimen measured approximately 2 cm x I cm x I cm. Stainless steel instruments (BS 2982 , British Standards Institution 1974 were used to dissect the samples which were transferred immediately to metal-free plastic storage containers. They were not fixed but stored at -20°C pending analysis. -- The specimens were freeze-dried in a Chemlab SB30 freezedrier and then taken to the Scottish Universities Research and Reactor Centre where the content of a wide range of trace elements was estimated by in vitro neutron activation analysis. Those performing the analysis did not know whether individual specimens came from the patient or the control group. The specimens were subjected to a thermal neutron flux from the Argonaut UTR300 reactor for two periods. The first was a 2 minute exposure to a flux of 3 x 1012 neutrons cm-2s-. Gamma emitting isotopes of sodium, potassium, chlorine, magnesium and manganese were formed as a result of this and the induced activity measured using an 80 cm3 Ge-Li detector. Gamma ray spectra were obtained by 4096 channel analysis and gamma peak count rates calculated using standard peak analysis and identification software. The samples were then exposed to a thermal flux of 1012 neutrons cm 2s-1 for 54 hours. Following this irradiation gamma emitting isotopes of chromium, iron, cobalt, zinc, rubidium, caesium, selenium and antimony were formed. On this occasion the induced activity was counted using a 130 cm3 Ge-Li detector and the gamma ray spectra were recorded and gamma peak count rates calculated as before. This enabled the content of these trace elements within each sample to be measured.
Statistical methods
Tests of significance between the two groups were based on the Wilcoxon rank sum test. The content of the trace elements at the three cord levels were compared using the Friedman two-way analysis of variance by ranks. In the absence of differences, the readings from the three sites were combined by taking the geometric mean of the three observations. Subsequent comparison of levels in the spinal cord between the control group and the motor neuron disease patients was then based on this combined measurement, rather than on the values from individual sites.
Results
The spinal cord manganese (p < 0 01) and selenium (p < 0-01) levels were significantly increased in the motor neuron disease patients. These results are plotted in figs 1 and 2 respectively. The hepatic selenium content was also significantly increased (p < 0 05) in the motor neuron disease patients. There was no correlation of the spinal level of either of these elements with age in the control group, duration of disease in the patient group or with the levels in liver or bone. The cord:liver ratios were also compared for each of these elements but again no statistically significant differences were found.
No difference between the two groups was shown for the spinal or hepatic levels of any of the other elements studied. Inspection of the data suggested that the cobalt content of the spinal cord might have been increased in the motor neuron disease patients but this was not statistically significant. No differences were found for the bone levels of any of the elements.
Discussion
As with any study of this type the acquisition of patient and control material is slow and the analysis time consuming. This is reflected in the small numbers of subjects in each group. Despite this, differences between the two groups have been shown for two elements in spinal cord and one in liver at the highest significance levels possible for these numbers. These findings are of interest with regard both to our understanding of the pathogenesis of motor neuron disease and the report of a reduced CSF cobalt level. An increased spinal cord manganese level (p < 001) was recently reported in six control subjects compared with seven motor neuron disease patients. 9 A previous report using a different method was only able to measure manganese in two patients and one control subject and although the anterior horn tissue manganese level was higher in the patients this clearly was not statistically significant. Manganese is also important in nucleic acid metabolism. It plays a role in RNA synthesis as an activating factor for RNA polymerase and although manganese seems to improve fidelity with respect to recognition of complementary bases, it also increases the error incorporation of deoxynucleotides into RNA. In common with other divalent ions, manganese also has the capacity to bind to specific loci in polynucleotides.23 These considerations are obviously important in relation to previous reports of an abnormality of nucleic acid metabolism in motor neuron disease and the results described here.
The results of this work in conjunction with the previously reported CSF study'1822 provide a new angle in our attempts to understand the pathogenesis of this disorder. They provide support for an underlying disorder of DNA transcription, but also suggest that it would be of interest to study free radicals in motor neuron disease. We are currently pursuing some of these implications and aim to study the distribution of trace elements within the nervous system in larger numbers of patients with this enigmatic disease.
